trametinib dimethyl sulfoxide
SpainDrugs containing this active substance
-
It is used in children aged 1 year and older to treat a type of brain tumor called glioma (low or high grade), provided the tumor has a specific mutation in the BRAF gene. It must be used in conjunction with another medication called dabrafenib.
Form: powder for oral solution
Active substance Dosage trametinib dimethyl sulfoxide 5,3 mg Manufacturer: Novartis Europharm Limited